Serum insulin-like growth factor binding protein 3 as a promising diagnostic and prognostic biomarker in esophagogastric junction adenocarcinoma

Serum insulin-like growth factor binding protein 3 as a promising diagnostic and prognostic biomarker in esophagogastric junction adenocarcinoma

Abstract Background Esophagogastric junction adenocarcinoma (EJA) lacks serum biomarkers to assist in diagnosis and prognosis. Here, we aimed to evaluate the diagnostic and prognostic value of serum insulin-like growth factor binding protein 3 (IGFBP3) in EJA patients. Methods 320 participants were...

Full description

Bibliographic Details
Main Authors: Tian-Yan Ding, Yu-Hui Peng, Chao-Qun Hong, Bin-Liang Huang, Can-Tong Liu, Yun Luo, Ling-Yu Chu, Biao Zhang, Xin-Hao Li, Qi-Qi Qu, Yi-Wei Xu, Fang-Cai Wu
Format: Article
Language:English
Published: Springer 2022-11-01
Series:Discover Oncology
Subjects:
IGFBP3
Nomogram
Diagnosis
Prognosis
Esophagogastric junction adenocarcinoma
Online Access:https://doi.org/10.1007/s12672-022-00591-1

Internet

https://doi.org/10.1007/s12672-022-00591-1

Similar Items